# Thrivent Small Cap Fund Q3 2026 Performance

> Thrivent Small Cap Fund matches Russell 2000 growth with AI-driven DNA demand.
- Title: Thrivent Small Cap Fund Q3 2026 Performance · Seekingalpha
- Summary: Thrivent Small Cap Fund matches Russell 2000 growth with AI-driven DNA demand. Thrivent Small Cap Fund grew in line with Russell 2000 in Q3 2026 as AI drug…
- Keywords: thrivent small cap stock fund, russell 2000 index, ai drug development, cloud migrations, non-human identity security, Seekingalpha
- URL: https://shortify.news/Seekingalpha/thrivent-small-cap-fund-q3-2026-performance
- Source: Seekingalpha — https://seekingalpha.com/article/4970507-thrivent-small-cap-stock-fund-q3-2026-commentary
- Read time: 1 min
- Topics: thrivent small cap stock fund, russell 2000 index, ai drug development, cloud migrations, non-human identity security, money, business
## Q3 2026 Performance
Thrivent Small Cap Fund performed roughly in-line with Russell 2000 Index over last quarter.
## AI Drug Development Growth
Easing academic funding headwinds and growing demand for large-scale DNA inputs in AI-driven drug development support stronger revenue expectations.
## Cloud Migrations Boost
We expect continued double-digit revenue growth supported near-term by cloud migrations and over time by demand to secure non-human identities.
## Portfolio Adjustments
The investment thesis around improving nuclear power orders, new JV services wins, and accelerating shipbuilding growth has largely played out.
## Key takeaway

Thrivent Small Cap Fund grew in line with Russell 2000 in Q3 2026 as AI drug development and cloud migrations boosted revenue.

---

Summary: Shortify — https://shortify.news/Seekingalpha/thrivent-small-cap-fund-q3-2026-performance
Reporting: Seekingalpha — https://seekingalpha.com/article/4970507-thrivent-small-cap-stock-fund-q3-2026-commentary

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.